<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02662738</url>
  </required_header>
  <id_info>
    <org_study_id>FDS-NAA-1650</org_study_id>
    <nct_id>NCT02662738</nct_id>
  </id_info>
  <brief_title>The Effect of a Natural Extract on Glucose Fluxes After Consumption of a Wheat Product</brief_title>
  <official_title>The Effect of a Natural Extract on Glucose Fluxes After Consumption of a Wheat Product</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Unilever R&amp;D</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Unilever R&amp;D</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to quantify the effect of a natural fruit extract added to a wheat product on
      the time needed to absorb 50% of the apparent total of available exogenous carbohydrate (RaE
      * Time). In addition the different glucose fluxes will be quantified (RaE, EGP and GCR)
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Actual">February 2016</completion_date>
  <primary_completion_date type="Actual">February 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>13C (13 carbon) and D-[6,6-2H2] glucose</measure>
    <time_frame>0-6 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total blood glucose (BG)</measure>
    <time_frame>0-2 hours and 0-4 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin</measure>
    <time_frame>0-2 hours and 0-4 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endogenous glucose production (EGP)</measure>
    <time_frame>0-2 hours and 0-4 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glucose clearance rate (GCR)</measure>
    <time_frame>0-2 hours and 0-4 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>13C Metabolites of glucose (metabolomics)</measure>
    <time_frame>0-2 hours and 0-4 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>12C Metabolites of glucose (metabolomics)</measure>
    <time_frame>0-2 hours and 0-4 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postprandial hormones (Gastric inhibitory polypeptide, glucagon-like peptide-1 and Glucagon)</measure>
    <time_frame>0-2 hours and 0-4 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Selected anti-oxidants (vitamin E (alpha-tocopherol), lycopene, retinol, alpha-carotene and beta-carotene)</measure>
    <time_frame>-5, 60, 120, 180, 240 and 300 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Haematocrit</measure>
    <time_frame>-5, 60, 120, 180, 240 and 300 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Concentration of key active in extract</measure>
    <time_frame>-5, 15, 30, 45, 60, 90, 120, 150, 180, 240, 300 and 360 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>13CO2 in breath</measure>
    <time_frame>30, 30, 60, 90,120, 150, 180 and every 30 minutes up to 6 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>A wheat product</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A wheat product (containing 2% 13C-universally-labeled wheat) with natural fruit extract added.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>A wheat product (containing 2% 13C-universally-labeled wheat) without natural fruit extract added.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Glucose solution</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>A solution of 50g glucose of which 2% 13C-universally-labeled glucose (2%) and unlabeled glucose (98%) in 250 mL water.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Natural fruit extract</intervention_name>
    <arm_group_label>A wheat product</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Glucose solution</intervention_name>
    <arm_group_label>Glucose solution</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy Caucasian male.

          -  Body mass index (BMI) ≥ 18.0 and ≤ 25.0 kg/m2.

          -  Apparently healthy: no medical conditions which might affect the study measurements
             including diabetes type 1 and type 2, gastrointestinal dysfunction, gastrointestinal
             surgery and inflammatory diseases.

          -  Fasting blood glucose value of volunteer is ≥ 3.4 and ≤ 6.1 mmol/liter (i.e. 62- 110
             mg/dl) at screening.

          -  HbA1c ≤ 6.5 % (48 mmol/mol).

        Exclusion Criteria:

          -  Use of antibiotics within 3 months before Day 1; use of any other medication except
             paracetamol within 14 days before Day 1.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tjeerd Mensinga, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>QPS Netherlands</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>QPS</name>
      <address>
        <city>Groningen</city>
        <state>Hanzeplein 1</state>
        <zip>9713 GZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 20, 2016</study_first_submitted>
  <study_first_submitted_qc>January 20, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 25, 2016</study_first_posted>
  <last_update_submitted>October 25, 2016</last_update_submitted>
  <last_update_submitted_qc>October 25, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Blood glucose</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

